JP Patent

JP6016915B2 — キナーゼ阻害剤として活性なアルキニル置換ピリミジニルピロール

Assigned to ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ · Expires 2016-10-26 · 10y expired

What this patent protects

Patent listed against Retevmo.

Drugs covered by this patent

Patent Metadata

Patent number
JP6016915B2
Jurisdiction
JP
Classification
—
Expires
2016-10-26
Drug substance claim
No
Drug product claim
No
Assignee
ネルビアーノ・メデイカル・サイエンシーズ・エツセ・エルレ・エルレ
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.